IV Push Medications

This article has been archived.
Please use for reference only.

Penn Home Infusion Team
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 1 de noviembre del 2001

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Palliative Radiotherapy Often Overused in Stage IV NSCLC

Oct 5, 2015

Not proven to further improve symptoms or quality of life; can have significant side effects

Stage III/IV Melanoma Patients at Risk for New Primaries

Dec 10, 2013

One-year incidence of 1.8 percent in stage III patients not treated with a BRAF inhibitor

No Therapy for ~20 Percent With Stage IV Solid Tumors

Jun 25, 2012

Factors linked to no treatment include older age, black race, lack of medical insurance, income